4-mercaptobenzoate has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, G; He, M; Li, J; Sun, T; Tang, X; Yu, M | 1 |
| Chen, Z; Gao, Z; Huang, Q; Li, S; Wang, J; Yang, J; Yin, Q; Yu, D | 1 |
2 other study(ies) available for 4-mercaptobenzoate and Alzheimer Disease
| Article | Year |
|---|---|
Isomeric Effect of Nano-Inhibitors on Aβ
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Benzoates; Gold; Humans; Isomerism; Metal Nanoparticles; Peptide Fragments; Protein Aggregates; Protein Folding; Salicylates; Sulfhydryl Compounds | 2021 |
SERS-Based Immunoassay Enhanced with Silver Probe for Selective Separation and Detection of Alzheimer's Disease Biomarkers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzoates; Biomarkers; Calibration; Female; Graphite; Humans; Immunoassay; Limit of Detection; Male; Metal Nanoparticles; Molecular Probes; Silver; Spectrum Analysis, Raman; Sulfhydryl Compounds; tau Proteins; X-Ray Diffraction | 2021 |